These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26457076)

  • 21. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
    Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
    Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
    Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance.
    Hosoi T; Matsuzaki S; Miyahara T; Shimizu K; Hasegawa Y; Ozawa K
    J Neurochem; 2015 May; 133(3):343-51. PubMed ID: 25662180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of etoposide combined with 15-deoxy-Δ
    Yamamoto Y; Koma H; Hiramatsu H; Abe M; Murakami K; Ohya A; Yagami T
    Mol Clin Oncol; 2014 Mar; 2(2):292-296. PubMed ID: 24649349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
    Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
    Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological and Pathological Roles of 15-Deoxy-Δ
    Yagami T; Yamamoto Y; Koma H
    Mol Neurobiol; 2018 Mar; 55(3):2227-2248. PubMed ID: 28299574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-Deoxy-Δ
    Wu YC; Jhao YT; Cheng YC; Chen Y
    Oncol Lett; 2017 Apr; 13(4):2569-2576. PubMed ID: 28454435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
    Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
    Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of Heme Oxygenase-1 by 15d-Prostaglandin J
    Yang CC; Hsiao LD; Shih YF; Chang CI; Yang CM
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-Deoxy-Δ
    Na HK; Yang H; Surh YJ
    J Cancer Prev; 2020 Jun; 25(2):100-110. PubMed ID: 32647651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
    Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
    Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.
    Zhang X; Wang JM; Gong WH; Mukaida N; Young HA
    J Immunol; 2001 Jun; 166(12):7104-11. PubMed ID: 11390455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low 15d-PGJ2 status is associated with oxidative stress in chronic obstructive pulmonary disease patients.
    Ma SX; Xie GF; Fang P; Tang MM; Deng YP; Lu YJ; Cao W; Fu L
    Inflamm Res; 2023 Feb; 72(2):171-180. PubMed ID: 36371490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
    Lin TN; Cheung WM; Wu JS; Chen JJ; Lin H; Chen JJ; Liou JY; Shyue SK; Wu KK
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):481-7. PubMed ID: 16385084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.